Diabetes drug tested in people with liver issues
NCT ID NCT06961643
Summary
This study looked at how a potential new diabetes medication, HRS-7535, is processed by the body and how safe it is in people with mild to moderate liver problems compared to people with normal liver function. It involved 24 adults to measure the drug's levels in the blood and check for side effects. The goal was to gather information to see if the drug's dosing needs to be adjusted for people with liver impairment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Provincial Infectious Disease Hospital
Zhengzhou, Henan, 450015, China
Conditions
Explore the condition pages connected to this study.